Moreover, MiR-378 promotes cellular transformation, at least in part, by targeting and inhibiting TOB2, which is further elucidated as a candidate tumor suppressor to transcriptionally repress proto-oncogene cyclin D1[31]. This evidence concerns the gene CCND1 and neoplasm.